Implementation of the Reference Pricing Methodology: How Will Re-registration of Prices for Vital and Essential Drugs Affect the Availability of Medicines?

  • The procedure for re-registration of prices for medicines in the event of their defect or the risk of its occurrence withing the framework of the legislative act 1771. Experience of law enforcement and ways to improve the procedure
  • From reactive to proactive response to the risks of pharmaceutical drug defect occurrence
  • An indicative method for assessing the cost of the pharmaceutical drug as a toll to ensure the availability of the pharmaceutical drugs
  • Establishment of a common rate of return for pharmaceutical drugs producers

 

Alexander Bykov

Alisa Dzhangiryants

Alexander Martynenko

Svetlana Askolskaya

Hourly Schedule

Monday, 26 April

14:00 - 15:20
Implementation of the Reference Pricing Methodology: How Will Re-registration of Prices for Vital and Essential Drugs Affect the Availability of Medicines?

Date

26 Apr 2021
Expired!

Time

Moscow time
14:00 - 15:20
Online Platform

Location

Online Platform

Organizer

Advantix Pharma
Phone
+442080892886
Email
pharma@advantix.co.uk
Website
https://pharma.advantix.online/en/